Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Kapp, P. Schmucker, C. Siemens, W. Brugger, T. Gorenflo, L. Röbl-Mathieu, M. Grummich, K. Thörel, E. Askar, M. Brotons, M. et al.,

Human papillomavirus (HPV) vaccination in women with conisation

  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Li, W. Jin, Y. Li, X. Jin, M.

Human papillomavirus and vaccine knowledge, willingness, and uptake among university students: a systematic review and meta-analysis

  • All age groups
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Brewer, S. K. Stefanos, R. Murthy, N. C. Asif, A. F. Stokley, S. Markowitz, L. E.

Human papillomavirus vaccination at age 9 or 10 years to increase coverage-a narrative review of the literature, United States 2014-2024

  • Americas
  • United States of America
  • Children
  • Adolescents
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Tao, T. Ni, Y. Shi, N. Yang, X. Jin, H.

Human papillomavirus vaccination coverage and willingness among women in mainland China: A meta-analysis based on the COM-B model

  • Western Pacific
  • China
  • Children
  • Adolescents
  • Adults
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Moran, C. Garcia-Iglesias, J. Kerr, C.

Human papillomavirus vaccination uptake among men who have sex with men living with HIV

  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Sun, J. Dong, S. Gong, J. Xie, J. Yan, H.

Human papillomavirus vaccination willingness and influencing factors among women in China: A systematic review and meta-analysis

  • Western Pacific
  • China
  • Children
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mengistie, B. A. Yirsaw, A. N. Lakew, G. Mekonnen, G. B. Shibabaw, A. A. Chereka, A. A. Kitil, G. W. Wondie, W. T. Abuhay, A. E. Getachew, E.

Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review

  • Africa
  • All age groups
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ la Cruz, R. A. R. D. Flores-Cordova, J. M. Calderon-Hernandez, C. C. Cahuapaza-Gutierrez, N. L. Ccallalli-Ruiz, N. A. Runzer-Colmenares, F. M.

Humoral and Cellular Immune Responses Against SARS-CoV-2 Following COVID-19 Vaccination in Older Adults: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Othman, A. A. Albargy, H.

Humoral immune response to mRNA-based influenza vaccines in older adults: a systematic review and meta-analysis of randomized controlled trials

  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Martinez-Serrano, A. Pulido-Fuentes, M. Notario-Pacheco, B. Palmar-Santos, A. M. Cobo-Cuenca, A. I. Diez-Fernandez, A.

Immunity Awareness-Strategies to Improve the Degree of Acceptance of Vaccines: A Systematic Review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
Methodological quality (AMSTAR 2):
Not applicable
Loading...